Short Interest in Aurora Cannabis Inc. (NASDAQ:ACB) Expands By 6.8%

Aurora Cannabis Inc. (NASDAQ:ACB - Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 2,810,000 shares, a growth of 6.8% from the October 15th total of 2,630,000 shares. Approximately 5.2% of the company's stock are sold short. Based on an average daily trading volume, of 1,030,000 shares, the short-interest ratio is presently 2.7 days.

Hedge Funds Weigh In On Aurora Cannabis

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Cubist Systematic Strategies LLC purchased a new position in shares of Aurora Cannabis in the second quarter worth $50,000. Mackenzie Financial Corp purchased a new position in Aurora Cannabis in the 2nd quarter worth about $113,000. Toronto Dominion Bank raised its position in Aurora Cannabis by 34,356.4% in the 2nd quarter. Toronto Dominion Bank now owns 18,951 shares of the company's stock worth $88,000 after buying an additional 18,896 shares during the last quarter. Headlands Technologies LLC lifted its stake in Aurora Cannabis by 98.8% during the 2nd quarter. Headlands Technologies LLC now owns 74,988 shares of the company's stock valued at $346,000 after acquiring an additional 37,269 shares during the period. Finally, TD Asset Management Inc purchased a new stake in shares of Aurora Cannabis during the 2nd quarter valued at about $255,000. 47.63% of the stock is owned by institutional investors.

Aurora Cannabis Trading Down 3.2 %

NASDAQ:ACB opened at $4.20 on Friday. The stock has a market cap of $230.33 million, a price-to-earnings ratio of -5.53 and a beta of 1.87. The company has a quick ratio of 1.88, a current ratio of 3.83 and a debt-to-equity ratio of 0.07. The company's 50 day moving average price is $5.52 and its 200-day moving average price is $5.88. Aurora Cannabis has a 52 week low of $2.84 and a 52 week high of $9.35.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.